HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 196 filers reported holding HERON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $64,000 | -37.3% | 11,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -14.3% | 11,200 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $119,000 | -60.3% | 11,100 | -42.5% | 0.00% | -66.7% |
| Q2 2021 | $300,000 | -11.5% | 19,300 | -7.7% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | -42.3% | 20,900 | -24.8% | 0.00% | -50.0% |
| Q4 2020 | $588,000 | +11.4% | 27,800 | -21.9% | 0.01% | 0.0% |
| Q3 2020 | $528,000 | +76.6% | 35,600 | +75.4% | 0.01% | +50.0% |
| Q2 2020 | $299,000 | -66.1% | 20,300 | -43.8% | 0.00% | -60.0% |
| Q1 2019 | $882,000 | -3.7% | 36,100 | +2.3% | 0.01% | -16.7% |
| Q4 2018 | $916,000 | -47.2% | 35,300 | -35.6% | 0.01% | -40.0% |
| Q3 2018 | $1,734,000 | +191.9% | 54,800 | +258.2% | 0.02% | +185.7% |
| Q2 2018 | $594,000 | -25.0% | 15,300 | -46.7% | 0.01% | -30.0% |
| Q1 2018 | $792,000 | +67.1% | 28,700 | +9.5% | 0.01% | +66.7% |
| Q4 2017 | $474,000 | +3.3% | 26,200 | -14.4% | 0.01% | 0.0% |
| Q1 2017 | $459,000 | – | 30,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |